Dr. Charles J. Duffy (IMAGE)
Caption
“Those with Alzheimer’s disease often have an abnormal buildup of plaques in their brain that contain a protein called beta-amyloid,” said Charles J. Duffy, MD, PhD, neurologist and Director of the Brain Health & Memory Center within the UH Neurological Institute. “Lecanemab is an IV medication designed to target and remove these plaques, and has the potential to slow cognitive and functional decline if started in the early stages of the disease. We’re happy to be able to offer this breakthrough treatment to our patients at UH.”
Credit
University Hospitals
Usage Restrictions
N/A
License
Original content